CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

VU0119498 10mg  | ≥98%

CSNpharm

VU0119498 is a M1 muscarinic receptor agonist with EC50 of 3.1 μM, and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.

More Information Supplier Page

VU0119498 100mg  | ≥98%

CSNpharm

VU0119498 is a M1 muscarinic receptor agonist with EC50 of 3.1 μM, and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.

More Information Supplier Page

VU0119498 5mg  | ≥98%

CSNpharm

VU0119498 is a M1 muscarinic receptor agonist with EC50 of 3.1 μM, and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.

More Information Supplier Page

VU0134992 hydrochloride 5mg  | ≥97%

CSNpharm

VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV.

More Information Supplier Page

VU0134992 hydrochloride 100mg  | ≥97%

CSNpharm

VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV.

More Information Supplier Page

VU0134992 hydrochloride 10mg  | ≥97%

CSNpharm

VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV.

More Information Supplier Page

VU0134992 hydrochloride 50mg  | ≥97%

CSNpharm

VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV.

More Information Supplier Page

VU6012962 100mg  | ≥98%

CSNpharm

VU6012962 is a CNS-penetrant metabotropic glutamate receptor 7 (mGlu7) negative allosteric modulator (NAM) with an IC50 of 347 nM.

More Information Supplier Page

VU6012962 50mg  | ≥98%

CSNpharm

VU6012962 is a CNS-penetrant metabotropic glutamate receptor 7 (mGlu7) negative allosteric modulator (NAM) with an IC50 of 347 nM.

More Information Supplier Page

VU6012962 5mg  | ≥98%

CSNpharm

VU6012962 is a CNS-penetrant metabotropic glutamate receptor 7 (mGlu7) negative allosteric modulator (NAM) with an IC50 of 347 nM.

More Information Supplier Page

VU6012962 10mg  | ≥98%

CSNpharm

VU6012962 is a CNS-penetrant metabotropic glutamate receptor 7 (mGlu7) negative allosteric modulator (NAM) with an IC50 of 347 nM.

More Information Supplier Page

VU6015929 5mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VU6015929 50mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VU6015929 100mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VU6015929 25mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VU6015929 10mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VU6015929 1mg  | ≥97%

CSNpharm

VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

More Information Supplier Page

VX-745 50mg  | ≥99%

CSNpharm

VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.

More Information Supplier Page

VX-745 1mg  | ≥99%

CSNpharm

VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.

More Information Supplier Page

VX-745 5mg  | ≥99%

CSNpharm

VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.

More Information Supplier Page

VX-745 10mg  | ≥99%

CSNpharm

VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.

More Information Supplier Page